PDF(1027 KB)
Inhibitory effect of nobiletin on airway mucus hypersecretion in model rats with chronic obstructive pulmonary disease and its molecular mechanism
Jialiang CHEN,Qi LI,Xiangdong ZHOU,Xiaomei CHEN,Feng LIU,Chang LIU,Youqing ZHONG,Liang LI
PDF(1027 KB)
PDF(1027 KB)
Inhibitory effect of nobiletin on airway mucus hypersecretion in model rats with chronic obstructive pulmonary disease and its molecular mechanism
Objective To discuss the effect of nobiletin (NOB) on airway hypersecretion in the rats with chronic obstructive pulmonary disease (COPD), and to clarify the molecular mechanism of endoplasmic reticulum stress (ERS) signaling pathway regulation. Methods A total of 45 SD rats were randomly divided into control group, model group, NOB group, endoplasmic reticulum stress inhibitor 4-phenylbutyric acid (4-PBA) group, and NOB+4-PBA group, and there were 9 rats in each group. Except for control group, all the rats in the other groups were exposed to smoke and intratracheally injected with lipopolysaccharide (LPS) to establish the COPD models. After successful modeling, the rats were injected with the corresponding drugs (50 mg·kg-1·d-1 NOB or 0.35 g·kg-1·d-1 4-PBA) once daily for 4 consecutive weeks. After the drug intervention, the pulmonary function indexes [dynamic compliance (Cdyn) and airway resistance (RL)] and arterial blood gase indexes [partial pressure of carbon dioxide (PaCO2) and oxygen partial pressure (PaO2)] of the rats in various groups were detected by small animal ventilator and blood gas analyzer. Hematoxylin and eosin (HE) staining was used to observe the hyperplasia of the goblet cells in lung tissue of the rats in various groups; enzyme-linked immunosorbent assay (ELISA) method was used to detect the levels of mucin 5AC (MUC5AC), interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) in bronchoalveolar lavage fluid (BALF) of the rats in various groups;real-time fluroscence quantitative PCR (RT-qPCR) method was used to detect the expression level of MUC5AC mRNA in lung tissue of the rats in various groups;Western blotting method was used to detcet the protein expression levels of MUC5AC and ERS-related proteins inositol-requiring enzyme 1α (IRE1α), activating transcription factor 6 (ATF6), CCAAT-enhancer-binding protein homologous protein (CHOP), and glucose-regulated protein 78 (GRP78) in lung tissue of the rats in various groups. Results Compared with control group,the number of airway goblet cells of the rats in model group was increased(P<0.05), the Cdyn and PaO2 levels were decreased (P<0.05), and the levels of RL and PaCO2 were increased (P<0.05); the levels of MUC5AC, IL-1β, TNF-α, and IL-6 in BALF and the expression levels of MUC5AC, IRE1α, ATF6, CHOP, and GRP78 proteins in lung tissue were increased (P<0.05). Compared with model group, the lung function, arterial blood gas indexes, and proliferation of airway goblet cells of the rats in NOB group, 4-PBA group, and NOB+4-PBA group were significant improved, the levels of IL-1β, TNF-α, and IL-6 in BALF and the expression levels of MUC5AC, IRE1α, ATF6, CHOP, and GRP78 proteins in lung tissue were increased(P<0.05); the rats in NOB+4-PBA group exhibited the best alleviation effect. Conclusion NOB can effectively alleviate the airway mucus hypersecretion in the rats with COPD, and its mechanism may be related to the suppression of MUC5AC overexpression mediated by ERS.
Nobiletin / Chronic obstructive pulmonary disease / Endoplasmic reticulum stress / Airway mucus
R563.9
| 1 | ZHANG C, ZHU W, MENG Q, et al. Halotherapy relieves chronic obstructive pulmonary disease by alleviating NLRP3 inflammasome-mediated pyroptosis[J]. Ann Transl Med, 2022, 10(23): 1279. |
| 2 | TANNER L, SINGLE A B. Animal models reflecting chronic obstructive pulmonary disease and related respiratory disorders: translating pre-clinical data into clinical relevance[J]. J Innate Immun, 2020, 12(3): 203-225. |
| 3 | LIN V Y, KAZA N, BIRKET S E, et al. Excess mucus viscosity and airway dehydration impact COPD airway clearance[J]. Eur Respir J, 2020, 55(1): 1900419. |
| 4 | ZHANG L, LUO B, TING Y, et al. SIRT1 attenuates endoplasmic reticulum stress and apoptosis in rat models of COPD[J]. Growth Factors, 2020, 38(2): 94-104. |
| 5 | SP N, KANG D Y, LEE J M, et al. Mechanistic insights of anti-immune evasion by nobiletin through regulating miR-197/STAT3/PD-L1 signaling in non-small cell lung cancer (NSCLC) cells[J]. Int J Mol Sci, 2021, 22(18): 9843. |
| 6 | 傅慧婷, 平键, 吴冬梅, 等. 泽漆化痰方对慢性阻塞性肺疾病气道黏液高分泌模型大鼠肺组织EGFR信号通路相关蛋白表达的影响[J]. 中医杂志,2021, 62(9): 802-807. |
| 7 | HE M, ZHANG G, SHEN F, et al. Effects of Z-VaD-Ala-Asp-Fluoromethyl ketone (Z-VAD-FMK) and Acetyl-Asp-Glu-Val-Asp-Aldehyde (Ac-DEVD-CHO) on inflammation and mucus secretion in mice exposed to cigarette smoke[J]. Int J Chron Obstruct Pulmon Dis, 2023, 18: 69-78. |
| 8 | LIU W, HOU H P, LI C F, et al. Effects of Shiwei Longdanhua formula on LPS induced airway mucus hypersecretion, cough hypersensitivity, oxidative stress and pulmonary inflammation[J]. Biomed Pharmacother, 2023, 163: 114793. |
| 9 | ROJAS D A, PONCE C A, BUSTOS A, et al. Pneumocystis exacerbates inflammation and mucus hypersecretion in a murine, elastase-induced-COPD model[J]. J Fungi (Basel), 2023, 9(4): 452. |
| 10 | LEE E H, SHIN M H, GI M, et al. Inhibition of pendrin by a small molecule reduces lipopolysaccharide-induced acute lung injury[J].Theranostics,2020,10(22):9913-9922. |
| 11 | HUGHES R, RAPSOMANIKI E, JANSON C, et al. Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study[J]. Respir Med, 2022, 200: 106921. |
| 12 | GAO C, PAN H, MA F, et al. Centipeda minima active components and mechanisms in lung cancer[J]. BMC Complement Med Ther, 2023, 23(1): 89. |
| 13 | GHASEMI-TARIE R, KIASALARI Z, FAKOUR M, et al. Nobiletin prevents amyloid β1-40-induced cognitive impairment via inhibition of neuroinflammation and oxidative/nitrosative stress[J]. Metab Brain Dis, 2022, 37(5): 1337-1349. |
| 14 | YUAN S, YE Z, LI Y, et al. Hypoglycemic effect of nobiletin via regulation of islet β-cell mitophagy and gut microbiota homeostasis in streptozocin-challenged mice[J]. J Agric Food Chem, 2022, 70(19):5805-5818. |
| 15 | LU R, XU K, QIN Y, et al. Network pharmacology and experimental validation to reveal effects and mechanisms of icariin combined with nobiletin against chronic obstructive pulmonary diseases[J]. Evid Based Complement Alternat Med, 2022, 2022: 4838650. |
| 16 | LI J, MA J, TIAN Y, et al. Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling[J]. J Ethnopharmacol, 2020, 257: 112796. |
| 17 | DUAN Q, ZHOU Y, YANG D. Endoplasmic reticulum stress in airway hyperresponsiveness[J]. Biomed Pharmacother, 2022, 149:112904. |
| 18 | YU Y, YANG A, YU G, et al. Endoplasmic reticulum stress in chronic obstructive pulmonary disease: mechanisms and future perspectives[J]. Biomolecules, 2022, 12(11): 1637. |
| 19 | ZAIDI MAL, MARGGRAF V, REPGES E, et al. Relevance of serum levels of the endoplasmic reticulum stress protein GRP78 (glucose-regulated protein 78 kDa) as biomarker in pulmonary diseases[J]. Cell Stress Chaperones, 2023, 28(3): 333-341. |
| 20 | WANG J, DING L, WANG K, et al. Role of endoplasmic reticulum stress in cadmium-induced hepatocyte apoptosis and the protective effect of quercetin[J]. Ecotoxicol Environ Saf, 2020, 241: 113772. |
| 21 | LI Y R, FAN H J, SUN R R, et al. Wuzi Yanzong Pill plays a neuroprotective role in parkinson’s disease mice via regulating unfolded protein response mediated by endoplasmic reticulum stress[J]. Chin J Integr Med, 2023, 29(1): 19-27. |
| 22 | MOON J Y, CHO S K. Nobiletin induces protective autophagy accompanied by ER-stress mediated apoptosis in human gastric cancer SNU-16 cells[J]. Molecules, 2016, 21(7): 914. |
| 23 | ZHANG B F, JIANG H, CHEN J, et al. Nobiletin ameliorates myocardial ischemia and reperfusion injury by attenuating endoplasmic reticulum stress-associated apoptosis through regulation of the PI3K/AKT signal pathway[J]. Int Immunopharmacol, 2019, 73: 98-107. |
/
| 〈 |
|
〉 |